The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Medical Molecular Biology

PI Yvonne Ceder

Our research

Prostate cancer is the most common cancer in men in industrialized countries, and the manifestation of distant metastasis is the major cause of cancer-related deaths in these men. Our research aims to deduce the role of post transcriptional regulation in prostate cancer initiation and progression. The current focus of our research is on RNA editing and m6A modification that alters the fate of RNA molecules involved in homeostasis. These modifications seem to be involved in cancer progression and modulate the immunogenicity of the transcripts. Our projects span basic RNA research, tumour biology, patient sample analyses and clinical collaborations for translational studies. It is our belief that increased understanding of RNA editing in prostate cancer metastasis could help design novel therapeutic strategies, as well as enable biomarker-based detection and monitoring cancer progression and subsequent metastatic spread.

Monocrome picture of Yvonne Ceder leaning against a concrete wall outside.

Yvonne Ceder

Phone: +46 46 222 64 52
Mail: yvonne [dot] ceder [at] med [dot] lu [dot] se

Personal research portal page

Team members

Margareta Persson

Stefania Kalogera

Klaudia Detkiewicz

Irem Cemile Eroglu

Lisbeth Verk

-

Click on the name to visit their personal research portal page.

Representative picture for the Lund University Research Portal, a highway.

Research portal

Visit the Medical Molecular Biology groups research portal via this link.

Last updated: 12 May 2025 | johanna [dot] verngren [at] med [dot] lu [dot] se